Safeguard Investment Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,611
Closed -$246K 120
2024
Q2
$246K Sell
10,611
-1,917
-15% -$48.4K 0.08% 88
2024
Q1
$360K Sell
12,528
-5,431
-30% -$163K 0.12% 66
2023
Q4
$590K Sell
17,959
-2,341
-12% -$63.7K 0.22% 46
2023
Q3
$566K Sell
20,300
-382
-2% -$12.5K 0.25% 46
2023
Q2
$705K Sell
20,682
-1,111
-5% -$34.9K 0.3% 40
2023
Q1
$655K Sell
21,793
-441
-2% -$13.7K 0.32% 40
2022
Q4
$628K Sell
22,234
-471
-2% -$14.9K 0.39% 41
2022
Q3
$746K Sell
22,705
-2,114
-9% -$77.6K 0.51% 36
2022
Q2
$1.14M Hold
24,819
0.7% 30
2022
Q1
$1.14M Sell
24,819
-776
-3% -$37K 0.78% 25
2021
Q4
$1.57M Sell
25,595
-824
-3% -$57K 0.91% 27
2021
Q3
$1.97M Sell
26,419
-5,650
-18% -$474K 1.28% 21
2021
Q2
$2.97M Buy
32,069
+267
+0.8% +$22.7K 2.11% 14
2021
Q1
$2.82M Buy
31,802
+23,590
+287% +$2.34M 2.52% 12
2020
Q4
$765K Buy
+8,212
New +$654K 0.68% 28

Other funds holding ARKG

Safeguard Investment Advisory Group's ARKG Position: Q3 2024 in Review

Safeguard Investment Advisory Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 10,611 shares — an estimated $246K sold.

Safeguard Investment Advisory Group first reported a position in ARKG in Q4 2020 and held it in 15 quarters. The position peaked at $2.97M in Q2 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Safeguard Investment Advisory Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 10,611 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $246K.
  • Safeguard Investment Advisory Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 15 quarters.
  • Safeguard Investment Advisory Group's ARK Genomic Revolution ETF position peaked at $2.97M in Q2 2021.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Safeguard Investment Advisory Group's 13F filing for Q3 2024, filed 14 Nov 2024.